Drug Discovery Program, Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO, USA.
Curr Opin Immunol. 2011 Aug;23(4):487-94. doi: 10.1016/j.coi.2011.05.010. Epub 2011 Jun 22.
Research on the pathogenesis of asthma has concentrated on initial stimuli, genetic susceptibilities, adaptive immune responses, and end-organ alterations (particularly in airway mucous cells and smooth muscle) as critical steps leading to disease. Recent evidence indicates that the innate immune cell response to respiratory viruses also contributes to the development of inflammatory airway disease. We further develop this concept by raising the issue that the interaction between host airway epithelial cells and respiratory viruses is another aspect of innate immunity that is also a critical determinant of asthma. We also introduce a rationale for how antiviral performance at the epithelial cell level might be improved to prevent acute infectious illness and chronic inflammatory disease caused by respiratory viruses.
哮喘发病机制的研究集中在初始刺激、遗传易感性、适应性免疫反应和终末器官改变(特别是在气道黏液细胞和平滑肌)上,这些是导致疾病的关键步骤。最近的证据表明,呼吸道病毒的固有免疫细胞反应也有助于炎症性气道疾病的发展。我们进一步提出了一个观点,即宿主气道上皮细胞与呼吸道病毒的相互作用是固有免疫的另一个方面,也是哮喘的一个关键决定因素。我们还介绍了一种原理,即如何提高上皮细胞水平的抗病毒性能,以预防由呼吸道病毒引起的急性传染病和慢性炎症性疾病。